NIMG-36. EVALUATION OF [18F]DASA-23 FOR NON-INVASIVE MEASUREMENT OF ABERRANTLY EXPRESSED PYRUVATE KINASE M2 IN GLIOMA: FIRST-IN-HUMAN STUDY

OBJECTIVES: We developed 1-((2-fluoro-6-(fluoro-[18F])phenyl)sulfonyl)-4-((4-methoxyphenyl)sulfonyl)piperazine ([18F]DASA-23) as a novel radiopharmaceutical to measure pyruvate kinase M2 levels by positron emission tomography (PET). PKM2 catalyzes the final step in glycolysis, the key process of tum...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Patel, Chirag, Beinat, Corinne, Haywood, Tom, Murty, Surya, Xie, Yuanyang, Recht, Lawrence, Nagpal, Seema, Thomas, Reena, Khalighi, Mohammad, Gandhi, Harsh, Holley, Dawn, Gambhir, Sanjiv
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Neuro-Imaging
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847186/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.706
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars